Evaluation of the effect of sulifenacin and tolterodine in the treatment of primary enuresis in childre
Phase 3
Recruiting
- Conditions
- pediatric primary enuresis.Nocturnal enuresisN39.44
- Registration Number
- IRCT20220520054929N1
- Lead Sponsor
- Zahedan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 66
Inclusion Criteria
Children with primary enuresis referred to the clinic of Ali Bin Abi Talib Hospital in Zahedan
Conscious consent to study
Patient availability during quarterly follow-up
Age 5 to 14 years
Exclusion Criteria
Structural disorders of the urinary tract
Neurological bladder
Psychiatric diseases
Previous allergy to drugs
History of taking medication (drug therapy) for enuresis
Urinary incontinence
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method